After Almac4 treatment, N-myc protein expression decreased in both MYCN-amplified and MYCN-nonamplified NB cell lines (Figure 7D), with concurrent decreases in EZH2 levels (Figure 5A–D,F,G). Here, EZH2 is linked to neuroblastoma.